Belgium Country Drug Report 2019
Belgium
Country Drug Report 2019
About this report
Sections
What are the long-term aims of drug policy in Belgium? How are these aims to be achieved? How is drug policy coordinated at national level?
Learn moreUnderstanding the costs of drug-related actions is an important aspect of policy evaluation.
Learn moreWhat substances and activities does Belgium control under its drug laws? What are the penalties for offences? How are new psychoactive substances controlled?
How many people in Belgium have ever used drugs? What drugs have they used? How many have used drugs recently? How many are using drugs in highly risky ways?
Learn moreWhat are the main infectious diseases linked to drug injecting in Belgium?
Learn moreHow many drug-related medical emergencies occurred in Belgium in the last year?
Learn moreHow many people died of drug overdoses or poisonings in Belgium in the last year?
Learn moreWhat part does prevention play in Belgium drug strategy. What are the main prevention approaches used in the country and who do they target?
Learn moreHow does Belgium measure in terms of provision of needle and syringe programmes, peer naloxone programmes, supervised drug consumption rooms and heroin-assisted treatment.
Learn moreWhich authorities are responsible for prison health in Belgium? What forms of drug treatment and harm reduction are provided in prisons, and how widely?
Which authorities are responsible for prison health in Belgium? What forms of drug treatment and harm reduction are provided in prisons, and how widely?
Learn moreWhat is done in Belgium to ensure that the prevention and treatment interventions used are effective and provide a good return on public expenditure?
In which areas of study is drug-related research carried out in Belgium? How is this research funded? Are any types of research emphasised in the national drug strategy?
What is known about drug supply and trafficking in Belgium? How pure or strong are the drugs available? What do they cost? What are the main aims of supply reduction efforts?
Learn morePartners
About our partner in Belgium
The national focal point is located within the Epidemiology and Public health division at Sciensano, the Belgian Health research Institute. Sciensano implements policies in response to the legal framework and the priorities of the Federal Minister for Health and the President of the Federal Public Service for Health, Food Chain Security and the Environment. The institute is the scientific reference in the field of public health and supports health policy and policymaking through innovative research, analyses, monitoring activities and expert advice. In order to make use of national drug-related data, cooperation and coordination between the NFP and many different regional partner organisations is vital owing to the assigned responsibilities regarding health policy.
Belgian national focal point
Head of Unit illicit Drugs • Reitox National Focal Point
Epidemiology and Public Health
Rue Juliette Wytsmanstraat 14
1050 Brussels
Tel. +32 2 642 50 34
Head of national focal point: Ms Lies Gremeaux
Additional resources submitted by our partner
Methodological note: Analysis of trends is based only on those countries providing sufficient data to describe changes over the period specified. The reader should also be aware that monitoring patterns and trends in a hidden and stigmatised behaviour like drug use is both practically and methodologically challenging. For this reason, multiple sources of data are used for the purposes of analysis in this report. Caution is therefore required in interpretation, in particular when countries are compared on any single measure. Detailed information on methodology and caveats and comments on the limitations in the information set available can be found in the EMCDDA Statistical Bulletin.